| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |